# Lysoclear, Inc.: Form D filings

Lysoclear, Inc., a pharmaceuticals company in Lafayette, NY, filed 2 Form D notices with the SEC in 2019. The latest, on March 4, 2019, reports $3 million sold of a $3 million offering to 5 investors.

Find out what Lysoclear, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Lysoclear%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Lysoclear%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Flysoclear-inc-1762648)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Lysoclear%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Lysoclear%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Flysoclear-inc-1762648)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2521 U.S. ROUTE 11, Lafayette, NY, 13084
- Phone: (315) 677-8400
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2016
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1762648

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 4, 2019 | Amendment | $3,000,000 | $3,000,000 | $0 | 5 | Dec 19, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1762648/000176264819000002/0001762648-19-000002-index.htm) |
| Jan 3, 2019 | New notice | $1,500,000 | $1,500,000 | $0 | 1 | Dec 19, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1762648/000176264819000001/0001762648-19-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kelsey Moody | Executive Officer, Director |  |
| Roger Bagg | Director |  |
| Aaron Wolfe | Director |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Mar 4, 2019](https://specstream.ai/data/form-d/week/2019-03-04) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Lysoclear, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).